180 related articles for article (PubMed ID: 23891970)
1. Invasion as target for therapy of glioblastoma multiforme.
Vehlow A; Cordes N
Biochim Biophys Acta; 2013 Dec; 1836(2):236-44. PubMed ID: 23891970
[TBL] [Abstract][Full Text] [Related]
2. Pleiotropic Chemotherapy to Abrogate Glioblastoma Multiforme Migration/Invasion.
Helson L; Majeed M
Anticancer Res; 2019 Jul; 39(7):3423-3427. PubMed ID: 31262865
[TBL] [Abstract][Full Text] [Related]
3. Computational Trials: Unraveling Motility Phenotypes, Progression Patterns, and Treatment Options for Glioblastoma Multiforme.
Raman F; Scribner E; Saut O; Wenger C; Colin T; Fathallah-Shaykh HM
PLoS One; 2016; 11(1):e0146617. PubMed ID: 26756205
[TBL] [Abstract][Full Text] [Related]
4. Recurrent glioblastoma multiforme: advances in treatment and promising drug candidates.
Simpson L; Galanis E
Expert Rev Anticancer Ther; 2006 Nov; 6(11):1593-607. PubMed ID: 17134364
[TBL] [Abstract][Full Text] [Related]
5. A New Investigational Perspective for Purines Against Glioblastoma Invasiveness.
Giuliani P; Zuccarini M; Carluccio M; Ziberi S; Di Iorio P; Caciagli F; Ciccarelli R
Curr Drug Targets; 2018; 19(16):1871-1881. PubMed ID: 29484991
[TBL] [Abstract][Full Text] [Related]
6. Overcoming the blood-brain tumor barrier for effective glioblastoma treatment.
van Tellingen O; Yetkin-Arik B; de Gooijer MC; Wesseling P; Wurdinger T; de Vries HE
Drug Resist Updat; 2015 Mar; 19():1-12. PubMed ID: 25791797
[TBL] [Abstract][Full Text] [Related]
7. An Experimenter's Guide to Glioblastoma Invasion Pathways.
de Gooijer MC; Guillén Navarro M; Bernards R; Wurdinger T; van Tellingen O
Trends Mol Med; 2018 Sep; 24(9):763-780. PubMed ID: 30072121
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of glioblastoma cell proliferation, migration and invasion by the proteasome antagonist carfilzomib.
Areeb Z; Stylli SS; Ware TM; Harris NC; Shukla L; Shayan R; Paradiso L; Li B; Morokoff AP; Kaye AH; Luwor RB
Med Oncol; 2016 May; 33(5):53. PubMed ID: 27098175
[TBL] [Abstract][Full Text] [Related]
9. PEITC inhibits human brain glioblastoma GBM 8401 cell migration and invasion through the inhibition of uPA, Rho A, and Ras with inhibition of MMP-2, -7 and -9 gene expression.
Chou YC; Chang MY; Wang MJ; Yu FS; Liu HC; Harnod T; Hung CH; Lee HT; Chung JG
Oncol Rep; 2015 Nov; 34(5):2489-96. PubMed ID: 26352173
[TBL] [Abstract][Full Text] [Related]
10. [The sodium pump could constitute a new target to combat glioblastomas].
Lefranc F; Mijatovic T; Kiss R
Bull Cancer; 2008 Mar; 95(3):271-81. PubMed ID: 18390407
[TBL] [Abstract][Full Text] [Related]
11. Integrin inhibitor cilengitide for the treatment of glioblastoma: a brief overview of current clinical results.
Scaringi C; Minniti G; Caporello P; Enrici RM
Anticancer Res; 2012 Oct; 32(10):4213-23. PubMed ID: 23060541
[TBL] [Abstract][Full Text] [Related]
12. MiR-203 downregulation is responsible for chemoresistance in human glioblastoma by promoting epithelial-mesenchymal transition via SNAI2.
Liao H; Bai Y; Qiu S; Zheng L; Huang L; Liu T; Wang X; Liu Y; Xu N; Yan X; Guo H
Oncotarget; 2015 Apr; 6(11):8914-28. PubMed ID: 25871397
[TBL] [Abstract][Full Text] [Related]
13. Mediators of glioblastoma resistance and invasion during antivascular endothelial growth factor therapy.
Lucio-Eterovic AK; Piao Y; de Groot JF
Clin Cancer Res; 2009 Jul; 15(14):4589-99. PubMed ID: 19567589
[TBL] [Abstract][Full Text] [Related]
14. miR-128 and miR-149 enhance the chemosensitivity of temozolomide by Rap1B-mediated cytoskeletal remodeling in glioblastoma.
She X; Yu Z; Cui Y; Lei Q; Wang Z; Xu G; Xiang J; Wu M; Li G
Oncol Rep; 2014 Sep; 32(3):957-64. PubMed ID: 25017996
[TBL] [Abstract][Full Text] [Related]
15. Antiglioma activity of curcumin-loaded lipid nanoparticles and its enhanced bioavailability in brain tissue for effective glioblastoma therapy.
Kundu P; Mohanty C; Sahoo SK
Acta Biomater; 2012 Jul; 8(7):2670-87. PubMed ID: 22484149
[TBL] [Abstract][Full Text] [Related]
16. Oct-3/4 promotes migration and invasion of glioblastoma cells.
Kobayashi K; Takahashi H; Inoue A; Harada H; Toshimori S; Kobayashi Y; Goto K; Sugimoto K; Yano H; Ohnishi T; Tanaka J
J Cell Biochem; 2012 Feb; 113(2):508-17. PubMed ID: 21938739
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapy for glioblastoma: current treatment and future perspectives for cytotoxic and targeted agents.
Minniti G; Muni R; Lanzetta G; Marchetti P; Enrici RM
Anticancer Res; 2009 Dec; 29(12):5171-84. PubMed ID: 20044633
[TBL] [Abstract][Full Text] [Related]
18. Small-molecule agonists of mammalian Diaphanous-related (mDia) formins reveal an effective glioblastoma anti-invasion strategy.
Arden JD; Lavik KI; Rubinic KA; Chiaia N; Khuder SA; Howard MJ; Nestor-Kalinoski AL; Alberts AS; Eisenmann KM
Mol Biol Cell; 2015 Nov; 26(21):3704-18. PubMed ID: 26354425
[TBL] [Abstract][Full Text] [Related]
19. Identification of MMP-9 specific microRNA expression profile as potential targets of anti-invasion therapy in glioblastoma multiforme.
Yan W; Zhang W; Sun L; Liu Y; You G; Wang Y; Kang C; You Y; Jiang T
Brain Res; 2011 Sep; 1411():108-15. PubMed ID: 21831363
[TBL] [Abstract][Full Text] [Related]
20. Novel cellular and post-genomic technologies in the treatment of glioblastoma multiforme (Review).
Bryukhovetskiy I; Bryukhovetskiy A; Khotimchenko Y; Mischenko P
Oncol Rep; 2016 Feb; 35(2):639-48. PubMed ID: 26548844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]